Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Assembly Biosciences (ASMB) Leases (2019 - 2025)

Assembly Biosciences has reported Leases over the past 7 years, most recently at $2.5 million for Q4 2025.

  • Quarterly results put Leases at $2.5 million for Q4 2025, down 18.54% from a year ago — trailing twelve months through Dec 2025 was $2.5 million (down 18.54% YoY), and the annual figure for FY2025 was $2.5 million, down 18.54%.
  • Leases for Q4 2025 was $2.5 million at Assembly Biosciences, down from $2.6 million in the prior quarter.
  • Over the last five years, Leases for ASMB hit a ceiling of $8.1 million in Q1 2021 and a floor of $844000.0 in Q3 2023.
  • Median Leases over the past 5 years was $2.9 million (2025), compared with a mean of $3.6 million.
  • Biggest five-year swings in Leases: tumbled 78.68% in 2023 and later surged 86.07% in 2025.
  • Assembly Biosciences' Leases stood at $6.0 million in 2021, then tumbled by 47.12% to $3.2 million in 2022, then decreased by 26.79% to $2.3 million in 2023, then surged by 31.21% to $3.1 million in 2024, then dropped by 18.54% to $2.5 million in 2025.
  • The last three reported values for Leases were $2.5 million (Q4 2025), $2.6 million (Q3 2025), and $2.8 million (Q2 2025) per Business Quant data.